The global wound debridement market size is anticipated to reach USD 7.17 billion by 2030, expected to expand at a CAGR of 6.2% during the forecast period, according to a new report by Grand View Research, Inc. Rising cases of injuries that require cleaning and removal of necrotic tissue are leading to increasing demand for wound debridement products.
Wound debridement products help in eliminating or reducing the load of microbes and toxins that inhibit wound healing. Increasing incidence of diabetes and obesity escalates the level of chronic wounds such as diabetic foot ulcers. As per the International Diabetes Federation, the incidence of diabetes is expected to reach 642.0 million by 2040. Prevention of wound infection is one of the major concerns for diabetic patients, making wound debridement vital. With the increase in the number of diabetics in the U.S., demand for wound debridement is on a rise. Burns are the most common wounds and account for around 195,000 deaths annually. This, in addition to rising awareness regarding the importance of wound debridement, is expected to positively affect the market in the coming years.
Development of advanced wound debridement products is also boosting the market growth. For instance, the launch of keratin-based wound care products that are used along with dressings has proven to be extremely helpful in wound re-epithelialization. The keratin matrix is absorbed in the wound and eliminates the need for a dressing change. Such developments are anticipated to create growth opportunities for market players in the coming years.
Request a free sample copy or view report summary: Wound Debridement Market Report
Gels accounted for the largest share by product in 2017 due to advantages such as no inflammation, reduced bleeding, and safe removal of necrotic tissues without causing infection
By wound type, diabetic foot ulcers are estimated to form the fastest growing segment due to the high prevalence of diabetes. About 15.0% of diabetic foot ulcers result in amputation. Therefore, need to heal the wound in its nascent stage is necessary
Asia Pacific is anticipated to witness fastest growth over the forecast period. Progressive economy, reforms to improve infrastructure, high unmet needs of a massive population, and availability of skilled labor is expected to drive the market in this region
Grand View Research has segmented the global wound debridement market on the basis of product, method, wound type, end-use, mode of purchase, and region:
Wound Debridement Product Outlook (Revenue, USD Million, 2018 - 2030)
Gels
Ointments & Creams
Surgical Devices
Medical Gauzes
Ultrasonic Devices
Others
Wound Debridement Method Outlook (Revenue, USD Million, 2018 - 2030)
Autolytic
Enzymatic
Surgical
Mechanical
Others
Wound Debridement Wound Type Outlook (Revenue, USD Million, 2018 - 2030)
Pressure Ulcers
Diabetic Foot Ulcers
Venous Leg Ulcers
Burn Wounds
Others
Wound Debridement End-use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals
Homecare
Others
Wound Debridement Mode of Purchase Outlook (Revenue, USD Million, 2018 - 2030)
Prescription
Over The Counter
Others
Wound Debridement Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
Thailand
South Korea
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
South Africa
Saudi Arabia
Kuwait
UAE
List of Key Players of Wound Debridement Market
Coloplast Corp.
Medline Industries
Smith & Nephew
ConvaTec Group PLC
Integra LifeSciences
B. Braun SE
Molnlycke Health Care AB
Brightwake Ltd.
Lohmann & Rauscher
3M
"The quality of research they have done for us has been excellent..."